Page results
-
Preparations for the festive season are in full swing in the UCLH Charity fundraising team.
-
At the Cognitive Disorders Clinic, all forms of cognitive disorder are seen; however, we have particular expertise in young onset dementia, familial dementias and unusual degenerative diseases.
-
The National Hospital for Neurology and Neurosurgery (NHNN) has one of the largest, most comprehensive programmes in Europe for the evaluation and medical and surgical treatment of epilepsy.
-
This patient information offers advice for patients suffering from long COVID regarding a healthy diet and nutrition.
-
The Neurogenetics Unit offers a fully integrated service encompassing clinical assessment, diagnosis, molecular genetic testing and counselling for neurogenetic conditions.
-
The Neurometabolic unit provides a unique range of investigations and clinical laboratory advice encompassing mitochondrial, neurotransmitter, pterin and amino acid disorders.
-
Typically, patient care is multidisciplinary led by consultant neuro-ophthalmologists and neurologists.
-
The department is responsible for a wide range of neurophysiological procedures, principally electromyography (EMG) and nerve conduction studies, EMG-guided botulinum toxin (BoTox) injections, electroencephalography (EEG), evoked potentials (EPs) and intra-operative monitoring (IOM)
-
This booklet explains what you can expect during recovery from your autologous stem cell transplant.
-
This phlebotomy service is appointment based only (persons who are solely requiring a blood test), including GP patients (Camden & Islington)
File results
-
FOI/2024/0513 - Robotic platforms for surgery costs/ contract
-
FOI/2024/0514 - Viscosupplementation injections/ spend
-
FOI/2024/0518 - Post partum balloons buying/ usage numbers
-
FOI/2024/0520 - Treatment of melanoma
-
FOI/2024/05523 - Dabrafenib + Trametinib cancer treatment for metastatic and adjuvant melanoma/ lung/ colorectal cancer
-
FOI/2024/0527 - Treatment for renal cell carcinoma
-
FOI/2024/0532 - Patient treatment/ care/ consent
-
FOI/2024/0356 - Treatment with Durvalumab and Nivolumab for biliary tract/ non-small cell lung cancer
-
FOI/2024/0543 - Guidelines, policies for the treatment of obesity/ pathways for Tier 3 or Tier 4 weight management services
-
FOI/2024/0395 - Treatment and services for duchenne muscular dystrophy